Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-03

Clinical Trial Update: Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating whether sodium bicarbonate can reduce radiation-induced oral mucositis in patients with nasopharyngeal carcinoma; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancinoma (NPC) | Phase 2, Phase 3 | Status: RECRUITING